{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:00:21Z","timestamp":1793829621310,"version":"4.6.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The association between blood eosinophil levels and the risk of increased exacerbations, acute respiratory failure (ARF) and mortality in chronic obstructive pulmonary diseases (COPD) remains controversial. This association may predict future exacerbations and clinical outcomes among patients with COPD. This study aimed to clarify the relationship between eosinophil count and risk of acute exacerbation, ARF and mortality s in patients with COPD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The data for this retrospective cohort study were collected from TriNetX, a global multicentre research database. Using the Global Collaborative Research Networks, patients aged &amp;gt; 40\u202fyears with a diagnosis of COPD were examined for the association between blood eosinophil counts and the risk of acute exacerbation during a 3-year follow-up period. Cox proportional hazard models and Kaplan\u2013Meier analysis were used to assess the risk of acute exacerbation between the non-eosinophilic (blood eosinophil counts &amp;lt;300 cells\/\u03bcL) and eosinophilic groups (\u2265300 cells\/\u03bcL) after propensity score matching. Other outcomes including survival and ARF, were also examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The non-eosinophilic group had a 1.27-fold lower risk of acute exacerbations of COPD (hazard ratio [HR], 0.790; 95% confidence interval [95% CI], 0.74\u20130.85; <jats:italic>p<\/jats:italic> &amp;lt;\u202f0.001), a 1.22-fold lower risk of all-cause mortality (HR, 0.818; 95% CI, 0.76\u20130.88; <jats:italic>p<\/jats:italic> &amp;lt;\u202f0.001) and a 1.39-fold lower risk of ARF (HR, 0.721; 95% CI, 0.66\u20130.78; <jats:italic>p<\/jats:italic> &amp;lt;\u202f0.001) compared to the eosinophilic group during the 3-year follow-up period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Increased eosinophil count may be linked to an elevated risk of exacerbation, respiratory failure, and mortality in COPD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1525709","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:13:04Z","timestamp":1756872784000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between eosinophil count and prognosis in chronic obstructive pulmonary disease patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Wan-Hsuan","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Wen","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Ming","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1164\/rccm.202301-0106PP","article-title":"Global initiative for chronic obstructive lung disease 2023 report: gold executive summary","volume":"207","author":"Agusti","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1916046","article-title":"Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD","volume":"383","author":"Rabe","year":"2020","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1164\/rccm.202201-0209PP","article-title":"Blood eosinophils and chronic obstructive pulmonary disease: a global initiative for chronic obstructive lung disease science committee 2022 review","volume":"206","author":"Singh","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1801219","DOI":"10.1183\/13993003.01219-2018","article-title":"Inhaled corticosteroids in COPD: friend or foe?","volume":"52","author":"Agusti","year":"2018","journal-title":"Eur Respir J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.chest.2019.02.406","article-title":"Low and high blood eosinophil counts as biomarkers in hospitalized acute exacerbations of COPD","volume":"156","author":"MacDonald","year":"2019","journal-title":"Chest"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/ejhf.600","article-title":"Reframing the association and significance of co-morbidities in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.2147\/COPD.S226783","article-title":"Peripheral blood eosinophil as a biomarker in outcomes of acute exacerbation of chronic obstructive pulmonary disease","volume":"14","author":"Wu","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/thorax.55.2.114","article-title":"Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations","volume":"55","author":"Bhowmik","year":"2000","journal-title":"Thorax"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1164\/ajrccm.164.9.2105011","article-title":"Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease","volume":"164","author":"Seemungal","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease","volume":"359","author":"Sethi","year":"2008","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1093\/eurheartj\/ehad344","article-title":"Sacubitril\/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF","volume":"14","author":"Vaduganathan","year":"2003","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5603\/ARM.2018.0042","article-title":"Neprilysin inhibitors as a new approach in the treatment of right heart failure in the course of chronic obstructive pulmonary disease. Response to the letter of Siniorakis et al","volume":"86","author":"Liczek","year":"2018","journal-title":"Adv Respir Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1183\/09031936.00162414","article-title":"Eosinophilic inflammation in COPD: prevalence and clinical characteristics","volume":"44","author":"Singh","year":"2014","journal-title":"Eur Respir J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.chest.2016.01.026","article-title":"Blood eosinophils and outcomes in severe hospitalized exacerbations of COPD","volume":"150","author":"Bafadhel","year":"2016","journal-title":"Chest"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S2213-2600(16)30148-5","article-title":"Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis","volume":"4","author":"Pavord","year":"2016","journal-title":"Lancet Respir Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1378\/chest.15-0915","article-title":"Is the eosinophil a leading villain in lung function decline?","volume":"148","author":"Brightling","year":"2015","journal-title":"Chest"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.chest.2016.10.003","article-title":"Eosinophils in COPD exacerbations are associated with increased readmissions","volume":"151","author":"Couillard","year":"2017","journal-title":"Chest"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"13451","DOI":"10.1038\/s41598-017-13745-x","article-title":"Eosinophilia and clinical outcome of chronic obstructive pulmonary disease: a meta-analysis","volume":"7","author":"Ho","year":"2017","journal-title":"Sci Rep"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","article-title":"Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen general population study","volume":"193","author":"Vedel-Krogh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/jcp.36.8.938","article-title":"Angiotensin-converting enzyme and its clinical significance--a review","volume":"36","author":"Studdy","year":"1983","journal-title":"J Clin Pathol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1700853","DOI":"10.1183\/13993003.00853-2017","article-title":"Impact and associations of eosinophilic inflammation in COPD: analysis of the aeris cohort","volume":"50","author":"Kim","year":"2017","journal-title":"Eur Respir J"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2174\/1381612033455396","article-title":"Cytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptor antagonists","volume":"9","author":"Molteni","year":"2003","journal-title":"Curr Pharm Des"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.2147\/COPD.S129787","article-title":"Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD","volume":"12","author":"Zysman","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1164\/rccm.201708-1684LE","article-title":"Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease","volume":"197","author":"Turato","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1440-1843.2009.01651.x","article-title":"Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease","volume":"15","author":"Holland","year":"2010","journal-title":"Respirology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41540-017-0013-4","article-title":"Mechanisms of action of sacubitril\/valsartan on cardiac remodeling: a systems biology approach","volume":"3","author":"Iborra-Egea","year":"2017","journal-title":"NPJ Syst Biol Appl"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.2147\/COPD.S88058","article-title":"Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?","volume":"10","author":"Salturk","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2147\/COPD.S265275","article-title":"Peripheral blood eosinophils and nine years mortality in COPD patients","volume":"16","author":"Prudente","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1164\/ajrccm.160.6.9811041","article-title":"Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample","volume":"160","author":"Hospers","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.amjms.2021.02.013","article-title":"Blood eosinophil levels and prognosis of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"362","author":"Yu","year":"2021","journal-title":"Am J Med Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"653777","DOI":"10.3389\/fmed.2021.653777","article-title":"Blood eosinophils and clinical outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease: a propensity score matching analysis of real-world data in China","volume":"8","author":"Cui","year":"2021","journal-title":"Front Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1164\/ajrccm.160.5.9810105","article-title":"Eosinophilic inflammation in stable chronic obstructive pulmonary disease: relationship with neutrophils and airway function","volume":"160","author":"Balzano","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1465-9921-10-113","article-title":"Eosinophil and t cell markers predict functional decline in COPD patients","volume":"10","author":"D'Armiento","year":"2009","journal-title":"Respir Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.rmed.2016.01.013","article-title":"Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort","volume":"112","author":"DiSantostefano","year":"2016","journal-title":"Respir Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1164\/rccm.201602-0353OC","article-title":"Asthma-like features and clinical course of chronic obstructive pulmonary disease. An analysis from the Hokkaido COPD cohort study","volume":"194","author":"Suzuki","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12931-018-0840-x","article-title":"Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease","volume":"19","author":"Shin","year":"2018","journal-title":"Respir Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1525709\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:13:05Z","timestamp":1756872785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1525709\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":41,"alternative-id":["10.3389\/fmed.2025.1525709"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1525709","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"article-number":"1525709"}}